Swiss company SkyCell bags 108M funding - Silicon Canals
Briefly

Richard Ettl highlights the significance of technology in the pharmaceutical industry's fast growth period, emphasizing the need to decarbonize the supply chain and the substantial CO2 savings achieved by SkyCell's solution.
Ettl discusses the shift towards digitalization in pharma supply chains, emphasizing the utilization of AI and vast data points to enhance cost efficiency and risk reduction, and the company's focus on creating sustainable logistics.
SkyCell, founded by Nico Ros and Richard Ettl, specializes in temperature-controlled hybrid containers and technological solutions for pharmaceutical supply chains, ensuring medicine protection and environmental conservation.
The new funding will support SkyCell's expansion globally, particularly in the US and Asia, showcasing the company's commitment to advancing sustainable solutions for the pharmaceutical sector.
Read at Silicon Canals
[
]
[
|
]